A team of researchers at Massachusetts Institute of Technology (MIT) has been refining and combining several advanced technologies over the past six years to create a revolutionary platform to treat a ...
When the living and breathing body of a 71-year-old Parkinson’s disease patient was recently lying in a sterile operating theater at the Galilee Medical Center in Nahariya, his head was in Thailand.
The announcement follows two years of accelerated testing and regulatory navigation. Neuralink launched its first human trial in 2024, two years after the US Food and ...